Apr 24, 2025
Cordis Announces Positive Results from Two Major Studies Demonstrating Durable Efficacy of SELUTION SLR Drug-Eluting Balloon in Complex Peripheral Artery Disease Patients.
Read more
Jun 18, 2024
Nov 16, 2023
Nov 6, 2023
Cordis Announces Scott Drake as Chief Executive Officer
Oct 31, 2023
Oct 24, 2023
Cordis announces the completion of patient enrollment in SELUTION SLR™ DEB SUCCESS PTA Study
Oct 2, 2023
Sep 5, 2023
Oct 17, 2022
Cordis Announces Acquisition of MedAlliance, Positioning Itself for Market Leadership in Drug-Eluting Balloon Technology